Table of Content

1. Market Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. High prevalence of cancer and cardiovascular disease
4.1.1.2. Rising demand for infection control measure
4.1.2. Restraints:
4.1.2.1. The short half-life of radiopharmaceuticals
4.1.3. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
5.4. Pricing Analysis
5.5. Unmet Needs
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Radioisotopes
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes Segment
7.1.2. Market Attractiveness Index, By Radioisotopes Segment
7.2. Tec.99 *
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. F18
7.4. Iodine 131
7.5. Lutetium 177
7.6. Yttrium 90
7.7. Gallium 68
7.8. Gallium 67
7.9. Rubidium 82
7.10. Iodine 123
7.11. Iodine 125
7.12. Indium 111
7.13. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
8.1.2. Market Attractiveness Index, By Application Segment
8.2. Oncology *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Cardiology
8.4. Gastroenterology
8.5. Neuroendocrinology
8.6. Neurology
8.7. Nephrology
8.8. Others
9. By Source
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
9.1.2. Market Attractiveness Index, By Source
9.2. Cyclotrons *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Nuclear Reactor
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
10.1.2. Market Attractiveness Index, By End User Segment
10.2. Hospitals*
10.2.1. Introduction
10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Diagnostic Imaging Centers
10.4. Ambulatory Surgical Centers
10.5. Cancer Research Institute
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. The U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Radioisotopes
11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Source
11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Treatment type Benchmarking
13. Company Profiles
13.1. Siemens AG*
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Positron Corporation
13.3. Curium
13.4. GE Healthcare
13.5. Lantheus Holdings Inc.
13.6. Sotera Health LLC
13.7. Bayer AG
13.8. Eckert & Ziegler
13.9. Novartis AG
13.10. BWX Technologies Inc.
LIST NOT EXHAUSTIVE
14. Global Radiopharmaceuticals market– DataM
14.1. Appendix
14.2. About Us and Services
14.3. Contact Us